Windlas Biotech Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 33,339 shares,. Its Average Traded Price (ATP) is ₹969.22, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3 @ ₹961.00.
Windlas Biotech has an upper circuit limit of ₹1178.90 and a lower circuit limit of ₹786.00. The total value traded stands at ₹3.23 CR, and the delivery percentage for the day is 59.53%.
The stock is currently traded with a market lot size of 1. Windlas Biotech also offers a dividend yield of 0.64%.
Windlas Biotech Share Price Chart
Windlas Biotech Share Key Metrics
Volume
33339.00
Market Cap
1983.66 CR
LTQ@LTP
3@961.00
ATP
969.22
Var Margin
20.29 %
Circuit Range
786-1178.9
Delivery %
59.53 %
Value
3.23 CR
ASM/GSM
No
Market Lot
1
Windlas Biotech Resistance and Support
Pivot 981.8
Resistance
First Resistance
989.6
Second Resistance
996.75
Third Resistance
1004.55
Support
First Support
974.65
Second Support
966.85
Third Support
959.7
Windlas Biotech Shareholding Pattern
View More- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Windlas Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
| 2026-08-10 | Quarterly Results |
| 2026-05-21 | Audited Results & Final Dividend |
| 2026-04-17 | Buy Back of Shares |
| 2026-02-05 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-16 | 2026-07-16 | View More |
| Buyback Period | ||
|---|---|---|
| 19 Nov - 26 Nov 26 12.30 pm | View More |
Windlas Biotech News
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Windlas Biotech reported Q2 FY27 revenue of Rs.264 crore, up 19% YoY, and adjusted PAT of Rs.25 crore, up 29% YoY. The company also announced the commercialization of Plant 6 and EUGMP certification for Plant-4 and Plant-5.
Nov 05 2026 17:48:25
Windlas Biotech Ltd - 543329 - Board Meeting Outcome for Outcome Of The Board Meeting Held On November 5, 2026
Windlas Biotech reported Q2 FY27 revenue of ₹263.91 crore, up 18.6% YoY, and a net profit of ₹18.05 crore. The board approved the appointment of MD Hitesh Windlass as Chairman. Additionally, Ashok Kumar Windlass stepped down as Whole-time Director to assume the role of Founder President.
Nov 05 2026 16:17:56
Windlas Biotech Ltd - 543329 - Board Meeting Intimation for Approval Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30, 2026
Windlas Biotech board of directors will meet on 5 Nov 2026. The primary agenda is to approve the financial results.
Oct 30 2026 12:26:54
Windlas Biotech Management
| Name | Position |
|---|---|
| Ananta Narayan Panda | Company Secretary & Compliance Officer |
| Ashok Kumar Windlass | Whole Time Director |
Windlas Biotech Similar Stocks
Sakar Healthcare Ltd.
1020.60
44.40 (4.55%)
Indoco Remedies Ltd.
232.15
-0.93 (0.40%)
Sai Parenteral's Ltd.
492.30
-3.10 (0.63%)
Panacea Biotec Ltd.
335.95
-16.90 (4.79%)
Syncom Formulations (India) Ltd.
21.90
-0.19 (0.86%)
Beta Drugs Ltd.
1655.40
-108.80 (6.17%)
Hester Biosciences Ltd.
2375.30
23.20 (0.99%)
Venus Remedies Ltd.
1491.00
-10.60 (0.71%)
Windlas Biotech FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in WINDLAS
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC